Clinical Trial Update: A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of controlled-release morphine in cancer patients with pain has completed. Sponsor: Egalet Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Controlled Release Morphine (CR Morphine) (morphine)

Snippet

Sponsor: Egalet Ltd | Conditions: Pain, Cancer | Phase 2 | Status: COMPLETED